Twitter | Search | |
The Nobel Prize Oct 1
This year’s constitutes a landmark in our fight against cancer. The discovery made by the two Medicine Laureates takes advantage of the immune system’s ability to attack cancer cells by releasing the brakes on immune cells.
Reply Retweet Like
The Nobel Prize
2018 laureate James P. Allison studied a protein that functions as a brake on the immune system. He realised the potential of releasing the brake and unleashing our immune cells to attack tumours. He developed this concept into a new approach for treating patients.
Reply Retweet Like More
The Nobel Prize Oct 1
Replying to @NobelPrize
Tasuku Honjo, awarded the 2018 , discovered a protein on immune cells and revealed that it also operates as a brake, but with a different mechanism of action. Therapies based on his discovery proved to be strikingly effective in the fight against cancer.
Reply Retweet Like
Igal Marcelo Zimmt Oct 1
Replying to @NobelPrize @JapanGov
congrats :)
Reply Retweet Like
Dr.Rohit Agrawal Oct 1
Replying to @NobelPrize
Congrats! Now that the ‘brakes’ have been identified, is it posible that applying them harder can keep a check on autoimmune diseases / transplant recipients too?
Reply Retweet Like
Sukesh Nagpure Oct 1
Replying to @NobelPrize @UN
विश्व में कुपोषण प्राकृतिक रक्षा करने में असफलता विश्व में प्रदूषण विश्व में सबसे बड़ा वायु प्रदूषण कैंसर जनित रोग का कारण है इसलिए भी समय गोबर गैस की क्रांति लाई जाए हमारे खेतों को प्राकृतिक जैविक गोबर खाद प्राप्त होगी प्राकृतिक की रक्षा होगी प्रदूषण से मुक्ति मिलेगी help me
Reply Retweet Like
Omar Bennouna Oct 1
Replying to @NobelPrize
Immune system w/o break can attack all cells This is a wrong advancement in cancer cure ??
Reply Retweet Like
Critical Thinker-Cradle To Grave! Oct 1
Replying to @NobelPrize
There are only two things to say about James P. Allison- W*O*W*, AND ⏬ From A Retired RN, BSN
Reply Retweet Like
OJ Oct 1
Replying to @oben99998 @NobelPrize
It’s an immune system without the brakes that the tumor microenvironment has put on it, not a immune system running rampant
Reply Retweet Like
Wesley G Oct 1
Replying to @NobelPrize
did he find what someone else put there?
Reply Retweet Like
SHAH_en_shah Oct 1
Replying to @NobelPrize
@MarkTwa77689907
Reply Retweet Like
biolution Oct 1
Replying to @NobelPrize
we conceptualised PD-1/PDL-1 interaction at the interface of B and T cell based on Improving our understanding of how tumours exploit this break on T cell activity to better tune anticancer T cell activity will be crucial to advance
Reply Retweet Like
Patty Kerr Oct 1
Replying to @NobelPrize
My husband had late stage melanoma in the brain and was taking Yervoy. Sadly, it wasn’t successful for him. Hoping it helps others suffering from this disease.
Reply Retweet Like
Colin Anderson Oct 1
Replying to @NobelPrize @rdekoter
and nice that the concept was first proposed at Western in 1971!
Reply Retweet Like
lifeontop MEDICINE Oct 1
Replying to @NobelPrize
Congratulations to both of them!
Reply Retweet Like
Kriya Reddy Oct 1
Replying to @NobelPrize
Interesting ! Hope the therapies comes in handy to even a normal earner .
Reply Retweet Like
Rodrigo Martins Oct 1
Replying to @rohit_dr @NobelPrize
Great question!
Reply Retweet Like
Akram Jamal Oct 2
Replying to @NobelPrize
This is a great discovery and well deserved award. Congratulations! Hope it will accessible to all class of people
Reply Retweet Like